These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30243682)
1. Schizophrenia dimension-specific antipsychotic drug action and failure in amphetamine-sensitized psychotic-like rats. Uzuneser TC; Schindehütte M; Dere E; von Hörsten S; Kornhuber J; Grömer TW; Müller CP Eur Neuropsychopharmacol; 2018 Dec; 28(12):1382-1393. PubMed ID: 30243682 [TBL] [Abstract][Full Text] [Related]
2. Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia. Bédard AM; Maheux J; Lévesque D; Samaha AN Schizophr Bull; 2013 May; 39(3):692-702. PubMed ID: 22927669 [TBL] [Abstract][Full Text] [Related]
3. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment. Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313 [TBL] [Abstract][Full Text] [Related]
4. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia. Gill KM; Cook JM; Poe MM; Grace AA Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874 [TBL] [Abstract][Full Text] [Related]
5. The α2C-adrenoceptor antagonist, ORM-10921, has antipsychotic-like effects in social isolation reared rats and bolsters the response to haloperidol. Uys M; Shahid M; Sallinen J; Dreyer W; Cockeran M; Harvey BH Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():108-16. PubMed ID: 27381554 [TBL] [Abstract][Full Text] [Related]
6. Changes in brain volume in response to estradiol levels, amphetamine sensitization and haloperidol treatment in awake female rats. Madularu D; Kulkarni P; Ferris CF; Brake WG Brain Res; 2015 Aug; 1618():100-10. PubMed ID: 26032742 [TBL] [Abstract][Full Text] [Related]
7. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function. El Hage C; Bédard AM; Samaha AN Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912 [TBL] [Abstract][Full Text] [Related]
8. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia. Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127 [TBL] [Abstract][Full Text] [Related]
9. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis. Feifel D; Reza T; Robeck S Neuropsychopharmacology; 1999 Feb; 20(2):141-9. PubMed ID: 9885794 [TBL] [Abstract][Full Text] [Related]
11. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Pillai A; Parikh V; Terry AV; Mahadik SP J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057 [TBL] [Abstract][Full Text] [Related]
12. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses]. Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M Encephale; 1995; 21(6):417-24. PubMed ID: 8674466 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood. Gao J; Li M Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():67-75. PubMed ID: 24942467 [TBL] [Abstract][Full Text] [Related]
14. Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficits. Phelps TI; Bondi CO; Ahmed RH; Olugbade YT; Kline AE J Neurotrauma; 2015 Apr; 32(8):590-7. PubMed ID: 25275833 [TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis? Arad M; Weiner I Neuropsychopharmacology; 2010 Jun; 35(7):1570-82. PubMed ID: 20237462 [TBL] [Abstract][Full Text] [Related]
16. Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040. Southam E; Cilia J; Gartlon JE; Woolley ML; Lacroix LP; Jennings CA; Cluderay JE; Reavill C; Rourke C; Wilson DM; Dawson LA; Medhurst AD; Jones DN Psychopharmacology (Berl); 2009 Jan; 201(4):483-94. PubMed ID: 18762914 [TBL] [Abstract][Full Text] [Related]
17. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis. Zipursky RB; Christensen BK; Daskalakis Z; Epstein I; Roy P; Furimsky I; Sanger T; Kapur S Can J Psychiatry; 2005 Jul; 50(8):462-9. PubMed ID: 16127964 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-like properties of 5-alpha-reductase inhibitors. Bortolato M; Frau R; Orrù M; Bourov Y; Marrosu F; Mereu G; Devoto P; Gessa GL Neuropsychopharmacology; 2008 Dec; 33(13):3146-56. PubMed ID: 18354385 [TBL] [Abstract][Full Text] [Related]
19. Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments. Zhang C; Fang Y; Xu L Schizophr Res; 2014 Nov; 159(2-3):376-84. PubMed ID: 25219486 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamine. Ko F; Tallerico T; Seeman P Synapse; 2006 Aug; 60(2):141-51. PubMed ID: 16715494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]